International Psoriasis Council

Advancing Knowledge. Improving Care.

Vimal

Hasmukh Prajapati

,

MD, FRCPC, DABD

Dermatologist
Skin Health & Wellness Centre, Dermatology Research Institute, Dermphi Centre, and University of Calgary
Calgary
,
Alberta
,
Canada
Councilor Since: January 23, 2024
IPC Councilor
Dr. Vimal Hasmukh Prajapati completed his dermatology residency at the University of Alberta, earning certification in both Canada and the United States. He then pursued an additional one-year fellowship in pediatric dermatology at Harvard Medical School. Dr. Prajapati has received 20 major awards at the regional and national level, authored one textbook chapter, published 108 peer-reviewed manuscripts in scientific journals, and presented 172 abstracts at scientific congresses regionally, nationally, and internationally. He also conducts clinical trials for adults and children, participating in 132 studies as an investigator and/or member of the global data monitoring or steering committee. Dr. Prajapati is a Clinical Associate Professor at the University of Calgary and co-founder and co-director of the Skin Health & Wellness Centre, Dermphi Centre, Dermphi Shop, and Dermatology Research Institute. His practice focuses exclusively on skin cancer and immune-mediated inflammatory diseases, specifically atopic dermatitis and psoriasis, as well as alopecia areata and vitiligo. Dr. Prajapati has also been appointed as a Councilor for the International Eczema Council (IEC) and International Psoriasis Council (IPC).
Last Updated:
06/03/2025

Areas of Interest

Dr. Vimal Hasmukh Prajapati is interested in therapeutics for psoriasis, including clinical trials, real-world experience with novel advanced topical and systemic therapies, and guidelines for psoriasis. He is also interested in advocating for patients to have access to new therapeutics.

IPC Committees / Groups

Pediatric Psoriasis Working Group

Languages Spoken

English

Involvement with Other Organization(s)

Dr. Prajapati has collaborated with the Canadian Skin Patient Alliance, Canadian Psoriasis Network, and National Psoriasis Foundation (NPF) on various initiatives. He also frequently advocates with provincial and national regulatory bodies for medications in Canada.

What's New

Use and Misuse of Systemic Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic corticosteroids in psoriasis. He questions whether they contraindicate the treatment of psoriasis, while also covering his personal experience in prescribing them.

WATCH NOW

Thursday, May 14, 2026

Use and Misuse of Topical Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids in psoriasis, covering current use, guidelines, and consequences.

WATCH NOW

Thursday, May 14, 2026

Videos Now Available from the IEC & IPC Joint Symposium at AAD

Missed the joint symposium hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the American Academy of Dermatology (AAD) Annual Meeting? Select presentations from Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script are now available, covering diagnostic overlap, emerging tools, treatment-related reactions, and practical strategies for managing complex cases across diverse patient populations.

WATCH NOW

Wednesday, May 27, 2026